Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.
Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This...
Glenmark Pharmaceuticals sets sights on FY28 for debut of oncology drugs and expansion of profit margins, reports ETPharma.
Glenmark Pharmaceuticals, a leading Indian pharmaceutical company, has expressed confidence that its cancer drug, Trastuzumab Rezetecan (SHR-A1811), will enter licensed markets by FY28, driving an improvement in both gross and EBITDA margins. The company has guided...
HOSMAC has designed Cipla’s Breathefree Lung Wellness Centre in Mumbai, focusing on adaptive reuse and a wellness-centric approach, as reported by Prop News Time.
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla's Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC's expertise in creating healthcare facilities that prioritize patient-centric care and wellness....
S&P Global Upgrades Biocon Biologics’ Credit Rating to ‘BB+’ with a Stable Outlook, Reports IndiaMedToday
S&P Global Ratings has upgraded the long-term issuer credit rating of Biocon Biologics, a subsidiary of Biocon Limited, to 'BB+' from 'BB'. The rating agency has also maintained a stable outlook for the company. This upgrade is a testament to Biocon Biologics' strong...
Hyderabad to Witness ‘Global Voices, One Vision’ International Health Dialogue 2026, Hosted by Apollo Hospitals
The 13th edition of the International Health Dialogue (IHD) will be hosted by Apollo Hospitals in Hyderabad on January 30 and 31, 2026. The event will bring together global leaders to discuss patient safety, healthcare innovation, and system-wide transformation. The...
Sun Pharma receives green light for obesity treatment injection similar to Wegovy.
Sun Pharmaceutical Industries has received approval for a weight loss injection similar to Novo Nordisk's Wegovy. The new treatment, called "SUN-144", is a once-weekly injection that helps with weight management in adults with obesity or overweight with at least one...
Lupin achieves top ESG rating from CDP for its efforts in addressing climate change and water security.
Lupin, a global pharmaceutical leader, has been recognized for its exceptional sustainability efforts, receiving the highest "A" leadership rating from the Climate Disclosure Project (CDP) for both Climate Change and Water Security. This prestigious recognition...
Zydus Lifesciences introduces India’s first biosimilar version of Nivolumab, a global breakthrough.
Zydus Lifesciences, a leading life sciences company, has launched the world's first biosimilar of nivolumab in India under the brand name Tishtha. This milestone marks a significant expansion of patient access to cutting-edge cancer therapies, particularly in the...
Sun Pharma receives green light for obesity treatment injection similar to Wegovy.
Sun Pharmaceutical Industries has received approval for a weight loss injection similar to Novo Nordisk's Wegovy. The new treatment, called "SUN-144", is a once-weekly injection that helps with weight management in adults with obesity or overweight with at least one...
Several major Indian pharmaceutical companies, including Sun Pharma, Cipla, Zydus, and Graviti, have issued recalls for certain medications in the United States market.
Several major pharmaceutical companies, including Sun Pharma, Cipla, Zydus, and Graviti Pharmaceuticals, are recalling various products in the US due to manufacturing issues, according to recent US FDA enforcement reports. The recalls are primarily related to problems...
Sun Pharma receives DCGI approval for generic version of Wegovy, plans March release ahead of Semaglutide patent expiration.
Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to launch a generic version of Novo Nordisk's Wegovy, a medication used to treat obesity. The approval comes as the patent for the active ingredient, semaglutide, is...
Sun Pharma Sets Sights on $10 Billion Organon Takeover to Bolster US Presence
Sun Pharmaceutical Industries Ltd., India's largest drug manufacturer, is considering a monumental acquisition of Organon, a US-based company specializing in women's health and biosimilars. The potential deal, valued at $10 billion, is being led by the company's...
US Sales of Revlimid Decline, Offset by Strong Domestic Market Growth
The Indian pharmaceutical industry is bracing for a challenging earnings season in Q3, with expectations of muted margins due to the loss of patent exclusivity for the blockbuster blood cancer drug Revlimid in the US. Revlimid, which has generated over $100 billion in...
Gather to observe ‘National Road Safety Day’
A rally emphasizing the importance of road safety was held in Visakhapatnam, India, on Tuesday, with thousands of participants, including employees from Divi's company, traffic police officials, and local villagers. The event was flagged off by Muralikrishna Divi, the...
Will Indian pharmaceuticals’ domestic offerings provide a buffer against pricing pressures from the US market in the third quarter?
The Indian pharmaceutical industry is expected to have a mixed third quarter, with domestic formulations and specialty launches driving growth despite US pricing pressure. Companies like Sun Pharmaceuticals and Lupin are likely to lead the way, driven by their...
Piramal Critical Care collaborates with Blue-Zone to launch innovative waste anaesthetic gas recycling initiative.
Piramal Critical Care, a leading provider of inhalation anaesthetics, has partnered with Blue-Zone Technologies, a pioneer in anaesthetic gas recycling, to launch a groundbreaking initiative aimed at reducing the environmental impact of waste anaesthetic gases. This...
Glenmark Pharmaceuticals sets sights on FY28 for debut of oncology drugs and expansion of profit margins, reports ETPharma.
Glenmark Pharmaceuticals, a leading Indian pharmaceutical company, has expressed confidence that its cancer drug, Trastuzumab Rezetecan (SHR-A1811), will enter licensed markets by FY28, driving an improvement in both gross and EBITDA margins. The company has guided...
HOSMAC has designed Cipla’s Breathefree Lung Wellness Centre in Mumbai, focusing on adaptive reuse and a wellness-centric approach, as reported by Prop News Time.
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla's Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC's expertise in creating healthcare facilities that prioritize patient-centric care and wellness....
S&P Global Upgrades Biocon Biologics’ Credit Rating to ‘BB+’ with a Stable Outlook, Reports IndiaMedToday
S&P Global Ratings has upgraded the long-term issuer credit rating of Biocon Biologics, a subsidiary of Biocon Limited, to 'BB+' from 'BB'. The rating agency has also maintained a stable outlook for the company. This upgrade is a testament to Biocon Biologics' strong...
Hyderabad to Witness ‘Global Voices, One Vision’ International Health Dialogue 2026, Hosted by Apollo Hospitals
The 13th edition of the International Health Dialogue (IHD) will be hosted by Apollo Hospitals in Hyderabad on January 30 and 31, 2026. The event will bring together global leaders to discuss patient safety, healthcare innovation, and system-wide transformation. The...
Sun Pharma receives green light for obesity treatment injection similar to Wegovy.
Sun Pharmaceutical Industries has received approval for a weight loss injection similar to Novo Nordisk's Wegovy. The new treatment, called "SUN-144", is a once-weekly injection that helps with weight management in adults with obesity or overweight with at least one...
Lupin achieves top ESG rating from CDP for its efforts in addressing climate change and water security.
Lupin, a global pharmaceutical leader, has been recognized for its exceptional sustainability efforts, receiving the highest "A" leadership rating from the Climate Disclosure Project (CDP) for both Climate Change and Water Security. This prestigious recognition...
Zydus Lifesciences introduces India’s first biosimilar version of Nivolumab, a global breakthrough.
Zydus Lifesciences, a leading life sciences company, has launched the world's first biosimilar of nivolumab in India under the brand name Tishtha. This milestone marks a significant expansion of patient access to cutting-edge cancer therapies, particularly in the...
HOSMAC has designed Cipla’s Breathefree Lung Wellness Centre in Mumbai, focusing on adaptive reuse and a wellness-centric approach, as reported by Prop News Time.
HOSMAC, a renowned healthcare design and consulting firm, has successfully designed Cipla's Breathefree Lung Wellness Centre in Mumbai. The centre is a testament to HOSMAC's expertise in creating healthcare facilities that prioritize patient-centric care and wellness....
Several major Indian pharmaceutical companies, including Sun Pharma, Cipla, Zydus, and Graviti, have issued recalls for certain medications in the United States market.
Several major pharmaceutical companies, including Sun Pharma, Cipla, Zydus, and Graviti Pharmaceuticals, are recalling various products in the US due to manufacturing issues, according to recent US FDA enforcement reports. The recalls are primarily related to problems...
Cipla Collaborates with ImmunoACT to Introduce CAR-T Cell Therapy for Blood Cancer Treatment in African Markets.
Cipla, a leading pharmaceutical company, has partnered with ImmunoACT, a biotech firm, to launch CAR-T cell therapy for the treatment of blood cancers in Africa. This collaboration aims to make this innovative and potentially life-saving treatment more accessible to...
US Sales of Revlimid Decline, Offset by Strong Domestic Market Growth
The Indian pharmaceutical industry is bracing for a challenging earnings season in Q3, with expectations of muted margins due to the loss of patent exclusivity for the blockbuster blood cancer drug Revlimid in the US. Revlimid, which has generated over $100 billion in...
Hyderabad to Witness ‘Global Voices, One Vision’ International Health Dialogue 2026, Hosted by Apollo Hospitals
The 13th edition of the International Health Dialogue (IHD) will be hosted by Apollo Hospitals in Hyderabad on January 30 and 31, 2026. The event will bring together global leaders to discuss patient safety, healthcare innovation, and system-wide transformation. The...
According to Apollo doctor, adopting three key lifestyle modifications can significantly safeguard cardiovascular well-being and reduce the risk of developing high blood pressure naturally.
High blood pressure, or hypertension, is a significant risk factor for cardiovascular disease, which is the leading cause of death worldwide. According to the World Health Organization (WHO), approximately 1.13 billion people globally suffer from hypertension, and...
Organs of Tiruppur road accident victim declared brain dead, donated to save multiple lives at Tiruchi hospital
A team of doctors at Apollo Speciality Hospitals in Tiruchi, India, successfully harvested organs from a 45-year-old brain-dead road accident victim, saving the lives of several patients in need of transplants. The woman, a resident of Kannivadi village in Tiruppur...
A 14-year-old patient suffering from sickle cell disease undergoes hip replacement surgery at Apollo Hospital.
A 14-year-old girl from Nigeria, Grace Natasha Mwanasa, has undergone a successful total hip replacement surgery at Indraprastha Apollo Hospital in New Delhi. The surgery, led by renowned orthopaedic surgeon Dr. Yash Gulati, is one of the youngest cases of total hip...
Apollo Hospitals Managing Director denies rumors of a family feud, citing the demerger as a deliberate business strategy.
Apollo Hospitals Enterprise is undergoing a significant restructuring process, spinning off its pharmacy and digital health businesses into a separate entity called Apollo HealthCo. Managing Director Suneeta Reddy has clarified that this decision is driven by a desire...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.